Jacob P Zaemes

Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report

P. Sackstein, Jacob P Zaemes, Chul-Eung Kim, 2021, Journal for ImmunoTherapy of Cancer.

A patient with melanoma that became sensitized to immunotherapy after treatment with a CDK4/6 inhibitor.

M. Atkins, Jacob P Zaemes, Ali Alzeer, 2020, Immunotherapy.

NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer

S. Bekiranov, M. Mayo, Brian D. McKenna, 2019, Cell Communication and Signaling.

Tyrosine Kinase Inhibition in a Lung Adenocarcinoma Patient With Dual G719S and S768I EGFR Mutations.

R. Gentzler, R. Hall, Jacob P Zaemes, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma

M. Atkins, G. Gibney, A. Radfar, 2021, Journal for ImmunoTherapy of Cancer.

Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature.

Chul Kim, Jacob P Zaemes, J. Zaemes, 2020, European journal of cancer.

Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report

Aakriti A. Arora, M. Ozdemirli, Jacob P Zaemes, 2023, Frontiers in Oncology.

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study

M. Atkins, Jaeil Ahn, A. Pecora, 2023, Cancer.

High levels of expression of Trop-2 in thymic epithelial tumors.

B. Kallakury, Jaeil Ahn, Stephen V. Liu, 2023, Lung cancer.